secwatch.observer — SEC 8-K summary
======================================

Issuer:     COGNITION THERAPEUTICS INC (CGTX)
CIK:        0001455365
Form:       8-K
Filed at:   2023-08-24T23:59:59+00:00
Accession:  0001104659-23-094705
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cognition Therapeutics files investor presentation; no material news disclosed
------------------------------------------------------------------------------

- Presentation covers general pipeline and Phase 3 preparation; no specific financial or clinical data.
- Agenda includes funding approach and commercialization readiness for neurodegenerative disorders.
- No earnings, trial results, or corporate action announced in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1455365/000110465923094705/0001104659-23-094705-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1455365/000110465923094705/tm2324678d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-094705

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer